Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Patterson Companies, Inc. (PDCO) Q3 2024 Earnings Call Transcript

The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Patterson Cos. (PDCO) Reports Q3 Earnings: What Key Metrics Have to Say

Patterson Companies' (PDCO) third-quarter fiscal 2024 results reflect an improvement in Dental Consumable sales, offset by lower Dental Equipment sales. Animal health sales appear weak.

Patterson Companies (PDCO) Misses on Q3 Earnings, Lowers EPS View

Patterson Cos. (PDCO) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.60 per share.

Patterson Cos. (PDCO) Q3 Earnings and Revenues Miss Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 third quarter ended January 27, 2024. “Patterson navigated a dynamic environment during our fiscal third quarter to deliver sales growth and gross margin expansion,” said Don Zurbay, President and CEO of Patterson Companies. “Our dental consumables and production animal businesses both continued to generate above-market sales growth, demonstrating the deep, differentia.

Patterson Companies Reports Fiscal 2024 Third Quarter Operating Results

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.

What's in Store for Patterson Companies (PDCO) in Q3 Earnings?

Evaluate the expected performance of Patterson Cos. (PDCO) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Patterson Cos. (PDCO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2024 third-quarter call on Wednesday, February 28, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2024 third-quarter earnings conference call replay will be available beginning at.

Patterson Companies Fiscal 2024 Third Quarter Conference Call Scheduled for Wednesday, February 28, 2024

Patterson Cos. (PDCO) closed at $28.40 in the latest trading session, marking a +0.18% move from the prior day.

Patterson Cos. (PDCO) Advances While Market Declines: Some Information for Investors

Patterson Cos. (PDCO) closed the most recent trading day at $29.09, moving +1.43% from the previous trading session.

Patterson Cos. (PDCO) Rises As Market Takes a Dip: Key Facts

Patterson Cos. (PDCO) closed the most recent trading day at $28.97, moving -0.52% from the previous trading session.

Patterson Cos. (PDCO) Stock Falls Amid Market Uptick: What Investors Need to Know

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today announced that Pamela Tomczik has been elected to the Patterson Companies Board of Directors, effective February 2, 2024. Ms. Tomczik currently serves as Senior Vice President, Treasurer and Corporate Development of Target Corporation, a general merchandise retailer with stores in all 50 states and the District of Columbia. Ms. Tomczik will serve on the Board's Audit and Finance Committee. “As we continue to enhanc.

Patterson Companies Elects Pamela Tomczik to Board of Directors

The latest trading day saw Patterson Cos. (PDCO) settling at $30.05, representing a +0.07% change from its previous close.

Patterson Cos. (PDCO) Rises But Trails Market: What Investors Should Know

Patterson Cos. (PDCO) concluded the recent trading session at $30.34, signifying a +1.71% move from its prior day's close.

Patterson Cos. (PDCO) Laps the Stock Market: Here's Why

In the most recent trading session, Patterson Cos. (PDCO) closed at $30.16, indicating a -0.56% shift from the previous trading day.

Patterson Cos. (PDCO) Stock Sinks As Market Gains: Here's Why

In the closing of the recent trading day, Patterson Cos. (PDCO) stood at $29.63, denoting a +0.73% change from the preceding trading day.

Patterson Cos. (PDCO) Surpasses Market Returns: Some Facts Worth Knowing

Patterson Cos. (PDCO) reported earnings 30 days ago.

Why Is Patterson Cos. (PDCO) Up 12.1% Since Last Earnings Report?

Cigna

DBV Technologies SA Sponsored ADR

Kintara Therapeutics

MEDNAX

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)

CVS Health

Kenvue

Premier

Select Medical Holdings

Spok Holdings

U.S. Physical Therapy

With concerns about a slowdown in the global economy rising, investors may be better served considering the top healthcare hidden-gem stocks. To be sure, no guarantees exist in the market; otherwise, everyone would pour money into the guaranteed space.

Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio

Patterson Companies revised its fiscal 2024 earnings guidance lower after facing softer market demand, sending shares tumbling on Wednesday. The company now expects its adjusted earnings per share (EPS) projection to be in the range of $2.35 to $2.45, compared to the previous guidance of $2.45 to $2.55.

Patterson Companies lowers FY2024 guidance amidst softening market demand

Patterson Companies, Inc. (NASDAQ:PDCO ) Q2 2024 Results Conference Call November 29, 2023 8:30 AM ET Company Participants John Wright - VP of Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair Jon Block - Stifel Jeff Johnson - Baird Kevin Caliendo - UBS Sameer Patel - Evercore ISI Allen Lutz - Bank of America John Stansel - JPMorgan Operator Thank you for standing by, and welcome to the Patterson Companies, Inc. Second Quarter Fiscal 2024 Earnings Conference Call. I would now like to welcome John Wright, VP of Investor Relations, to begin the call.

Patterson Companies, Inc. (PDCO) Q2 2024 Earnings Call Transcript

Patterson Companies' (PDCO) second-quarter fiscal 2024 results reflect improvement in Dental Consumable sales, which were offset by lower Dental Equipment sales. Animal health sales improve.

Patterson Companies (PDCO) Q2 Earnings Miss, EPS View Lowered

The headline numbers for Patterson Cos. (PDCO) give insight into how the company performed in the quarter ended October 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Patterson Cos. (PDCO) Q2 Earnings: A Look at Key Metrics

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2024 second quarter ended October 28, 2023. “Our team executed well against softer than anticipated demand within our end markets,” said Don Zurbay, President and CEO of Patterson Companies. “Steady patient traffic supported strong performance in our broad and resilient dental consumables portfolio that was offset by lower sales in certain high-tech dental equipment categor.

Patterson Companies Reports Fiscal 2024 Second Quarter Operating Results

Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments.

News for Patterson Companies Stock (PDCO)